|
|
Browse products Anticancer agents in preclinical trials Anticancer molecular libraries Other drug agents
|
MedKoo product information:
CKI27
Description of CKI27 (RG7304): CKI27 is a MEK inhibitor currently in clinical trials.
Current developer: Roche/Chugai Pharmaceuticals.
CKI (RG7304) is a MEK inhibitor currently in clinical trials.
|
Contact MedKoo: Email: sales@medkoo.com
(Keyword; CAS#; MedKoo code#)
|
||||||||||||||
About us | Services | Products | News | Careers | Contact us